Skeletal Dysplasia Account Manager - San Antonio/Austin

BridgeBio
Dallas, Houston, San Antonio, New Orleans, Nashville, Phoenix, Oklahoma City
Workplace: HybridFull timeUSD 155,000 - 210,000 annuallyFunction: Customer Success & Account ManagementExperience: 4-10 yearsEducation: bachelorsSkills: ["Analytical skills","Resilience","Confidence","Relationship building","Influence","Organizational skills","Learning agility","Integrity","Communication"]

Drive the launch of Infigratinib for achondroplasia by building and executing territory business plans across multiple Southwest territories. Engage healthcare providers and multidisciplinary clinic teams with deep product and clinical expertise, using sales and target data to identify growth opportunities and proactively address challenges. Partner compliantly with Field Medical and reimbursement teams, maintain KOL relationships, and collaborate across BridgeBio to deliver measurable launch success.

Loading

Loading job details...

Preparing the role view and application actions.

FursaFursa
BridgeBio
BridgeBio
1 month ago

Skeletal Dysplasia Account Manager - San Antonio/Austin

✓ Verified Job

Canonical indexed version, validated from employer's careers page.

Source: Company careers pageValidated by: Fursa AI
Last checked: 11 hours agoStatus: Live

Job Summary

Drive the launch of Infigratinib for achondroplasia by building and executing territory business plans across multiple Southwest territories. Engage healthcare providers and multidisciplinary clinic teams with deep product and clinical expertise, using sales and target data to identify growth opportunities and proactively address challenges. Partner compliantly with Field Medical and reimbursement teams, maintain KOL relationships, and collaborate across BridgeBio to deliver measurable launch success.
Location: Dallas, Houston, San Antonio, New Orleans, Nashville, Phoenix, Oklahoma City
Workplace: Hybrid
Employment Type: Full time
Job Function: Customer Success & Account Management
Seniority: Mid level

Key Responsibilities

  • •Develop and execute a territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and skeletal dysplasia clinic teams to meet and exceed sales goals.
  • •Demonstrate deep expertise in Infigratinib and the skeletal dysplasia landscape, engaging HCPs in clinically relevant, compliant discussions.
  • •Use sales and target data to identify growth opportunities and address territory challenges proactively.
  • •Partner compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer and family satisfaction.
  • •Build and maintain relationships with KOLs with Marketing and Medical Affairs to expand advocacy for Infigratinib and BridgeBio, operating with a “One Bridge” mindset.
Travel: Extensive travel

Pay and Benefits

Salary: USD 155,000 - 210,000 annually
Equity and Bonus:Equity
Perks:Health InsuranceDentalVision401kEquityPaid LeaveParental Leave

Key Requirements

  • •8–10 years in pharmaceutical or biotech, with 4+ years in rare disease, genetic disease, or skeletal dysplasia (achondroplasia or pediatric rare disease experience preferred).
  • •BS/BA required; MBA a plus.
  • •Willingness to travel extensively.
  • •Proven record launching products into competitive or new markets, including creating demand through disease-state and stakeholder education.
  • •Account management success analyzing complex accounts, building strategy, and driving implementation to deliver measurable impact.
Experience:4-10 yearsBiopharmaPharmaceuticalRare diseaseGenetic diseaseSkeletal dysplasiaPediatric rare disease
Education:Bachelor's
Skills:Analytical skillsResilienceConfidenceRelationship buildingInfluenceOrganizational skillsLearning agilityIntegrityCommunication
Languages:English
Tech Stack:AI

Company Brief

BridgeBio
Develops medicines for patients with genetic diseases by advancing targeted therapeutics from discovery through clinical development and commercialization, focusing on genetically defined diseases with high unmet medical need.
Industry: Biotech
Company Size: Large (251 to 1,000 employees)
Growth: Public Company
Valuation: Public Company (Market Cap in USD)
Funding: IPO / Publicly Listed
Headquarters: Palo Alto, United States
Founded: 2015
WebsiteLinkedIn